These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12243465)

  • 1. Mast cell tumors of the gastrointestinal tract in 39 dogs.
    Ozaki K; Yamagami T; Nomura K; Narama I
    Vet Pathol; 2002 Sep; 39(5):557-64. PubMed ID: 12243465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell lymphoma with eosinophilic infiltration involving the intestinal tract in 11 dogs.
    Ozaki K; Yamagami T; Nomura K; Narama I
    Vet Pathol; 2006 May; 43(3):339-44. PubMed ID: 16672580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R; Morini M; Sarli G
    J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
    Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.
    Ginn PE; Fox LE; Brower JC; Gaskin A; Kurzman ID; Kubilis PS
    Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.
    Pryer NK; Lee LB; Zadovaskaya R; Yu X; Sukbuntherng J; Cherrington JM; London CA
    Clin Cancer Res; 2003 Nov; 9(15):5729-34. PubMed ID: 14654558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
    Fernandez NJ; West KH; Jackson ML; Kidney BA
    Vet Pathol; 2005 Jul; 42(4):437-45. PubMed ID: 16006603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine mast cell tumors express stem cell factor receptor.
    Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
    Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
    Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
    Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
    Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
    Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal stromal tumors and leiomyomas in the dog: a histopathologic, immunohistochemical, and molecular genetic study of 50 cases.
    Frost D; Lasota J; Miettinen M
    Vet Pathol; 2003 Jan; 40(1):42-54. PubMed ID: 12627712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for in vivo mitosis by granule-containing mast cells from canine mastocytomas.
    Curry A; Jeziorska M; Woolley DE
    Virchows Arch; 1998 Nov; 433(5):465-70. PubMed ID: 9849862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
    Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A
    Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.
    Scase TJ; Edwards D; Miller J; Henley W; Smith K; Blunden A; Murphy S
    J Vet Intern Med; 2006; 20(1):151-8. PubMed ID: 16496935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.
    Hämäläinen S; Kareinen L; Sukura A; Kareinen I
    Vet Pathol; 2022 Mar; 59(2):236-243. PubMed ID: 34894899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours.
    Schlieben P; Meyer A; Weise C; Bondzio A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 May; 148(4):318-22. PubMed ID: 22935087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.